Farmers Trust CO Bristol Myers Squibb CO Transaction History

Farmers Trust CO

$570 Million
Q4 2025

A detailed history of Farmers Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Farmers Trust CO holds 6,495 shares of BMY stock, worth $304,030. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,495

Previous 6,261 3.74%

Holding current value

$304,030

Previous $282,000 7.8%

% of portfolio

0.05%

Previous 0.05%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 06, 2026	BUY	$42.6 - $49.08 $9,968 - $11,484	234 Added 3.74%	6,495 $304,000
Q3 2025 Oct 01, 2025	BUY	$43.31 - $48.98 $18,623 - $21,061	430 Added 7.37%	6,261 $282,000
Q2 2025 Jul 14, 2025	SELL	$44.12 - $59.6 $87,489 - $118,186	-1,983 Reduced 25.38%	5,831 $269,000
Q1 2025 Apr 04, 2025	SELL	$53.9 - $63.11 $10,348 - $12,117	-192 Reduced 2.4%	7,814 $476,000
Q4 2024 Jan 08, 2025	SELL	$51.92 - $59.94 $44,028 - $50,829	-848 Reduced 9.58%	8,006 $452,000

Q3 2024 Oct 03, 2024	SELL	$39.66 - $51.75 $5,948 - $7,762	-150 Reduced 1.67%	8,854 $458,000
Q2 2024 Jul 16, 2024	SELL	$40.25 - $52.99 $7,647 - $10,068	-190 Reduced 2.07%	9,004 $373,000
Q1 2024 Apr 09, 2024	BUY	$47.98 - $54.4 $3,214 - $3,644	67 Added 0.73%	9,194 $498,000
Q4 2023 Jan 09, 2024	BUY	$48.48 - $57.85 $13,332 - $15,908	275 Added 3.11%	9,127 $468,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $8,683 - $9,709	150 Added 1.72%	8,852 $513,000
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $58,039 - $64,444	911 Added 11.69%	8,702 $556,000
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $8,213 - $9,316	-125 Reduced 1.58%	7,791 $539,000
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $36,499 - $43,220	533 Added 7.22%	7,916 $570,000
Q3 2022 Oct 05, 2022	SELL	$0.13 - $76.84 $65 - $38,420	-500 Reduced 6.34%	7,383 $525,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $6,681 - $7,358	92 Added 1.18%	7,883 $607,000
Q1 2022 Apr 05, 2022	SELL	$61.48 - $73.72 $4,611 - $5,529	-75 Reduced 0.95%	7,791 $569,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $12,013 - $14,004	-224 Reduced 2.77%	7,866 $490,000
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $8,283 - $9,703	140 Added 1.76%	8,090 $481,000
Q2 2021 Jul 02, 2021	SELL	$61.91 - $67.42 $7,119 - $7,753	-115 Reduced 1.43%	7,950 $531,000
Q1 2021 Apr 09, 2021	SELL	$59.34 - $66.74 $20,887 - $23,492	-352 Reduced 4.18%	8,065 $509,000
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $19,169 - $21,722	332 Added 4.11%	8,417 $522,000
Q3 2020 Oct 07, 2020	BUY	$57.43 - $63.64 $5,168 - $5,727	90 Added 1.13%	8,085 $487,000
Q2 2020 Jul 06, 2020	BUY	$54.82 - $64.09 $8,223 - $9,613	150 Added 1.91%	7,995 $470,000
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $79,483 - $115,507	-1,713 Reduced 17.92%	7,845 $438,000
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $15,451 - $20,155	-314 Reduced 3.18%	9,558 $614,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $2,138 - $2,535	-50 Reduced 0.5%	9,872 $500,000
Q2 2019 Jul 09, 2019	SELL	$44.62 - $49.34 $13,386 - $14,802	-300 Reduced 2.93%	9,922 $450,000
Q1 2019 Apr 09, 2019	BUY	$45.12 - $53.8 $14,393 - $17,162	319 Added 3.22%	10,222 $488,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $19,504 - $25,292	-400 Reduced 3.88%	9,903 $515,000
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $11,148 - $12,574	202 Added 2.0%	10,303 $639,000
Q2 2018 Jul 09, 2018	SELL	$50.53 - $62.98 $4,396 - $5,479	-87 Reduced 0.85%	10,101 $559,000
Q1 2018 Apr 13, 2018	SELL	$59.92 - $68.98 $14,260 - $16,417	-238 Reduced 2.28%	10,188 $645,000
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $23,256 - $25,355	388 Added 3.87%	10,426 $638,000
Q3 2017 Oct 06, 2017	BUY	$55.23 - $63.74 $554,398 - $639,822	10,038	10,038 $639,000

Others Institutions Holding BMY

# of Institutions

2,684

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Farmers Trust CO with notifications on news.

Account